← All Cg Oncology, INC filings

Cg Oncology, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
CGON
Cg Oncology, INC
SCHEDULE: CG Oncology: Seven Fleet Amends 13D on Ownership Restructuring
Seven Fleet Master Fund LP and related entities filed an amended Schedule 13D for CG Oncology, Inc., detailing an internal ownership restructuring and correcting prior reporting.
NASDAQ
CGON
Cg Oncology, INC
SCHEDULE: Longitude Capital Boosts CG Oncology Stake to 6%
Longitude Capital and its affiliates, including Patrick G. Enright and Juliet Tammenoms Bakker, have increased their beneficial ownership in CG Oncology, Inc. to 6.0%, triggering a Schedule 13D filing.
NASDAQ
CGON
Cg Oncology, INC
SCHEDULE: Seven Fleet Boosts CG Oncology Stake to 1.9%
Seven Fleet Partners LP, Seven Fleet Advisors LLC, and Dr. Brian Liu have collectively reported a 1.9% beneficial ownership stake in CG Oncology, Inc., citing an attractive investment opportunity.